AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $748,000 | -1.8% | 26,458 | -23.0% | 0.05% | +24.3% |
| Q2 2022 | $762,000 | +24.9% | 34,365 | +64.0% | 0.04% | +8.8% |
| Q1 2022 | $610,000 | -35.9% | 20,954 | -27.6% | 0.03% | -2.9% |
| Q4 2021 | $951,000 | +23.2% | 28,931 | +73.0% | 0.04% | -12.5% |
| Q3 2021 | $772,000 | -15.6% | 16,724 | +0.8% | 0.04% | +2.6% |
| Q2 2021 | $915,000 | +286.1% | 16,597 | +204.0% | 0.04% | +95.0% |
| Q4 2020 | $237,000 | -49.1% | 5,460 | -58.9% | 0.02% | -60.8% |
| Q3 2020 | $466,000 | +31.6% | 13,300 | +101.0% | 0.05% | -13.6% |
| Q2 2020 | $354,000 | +26.4% | 6,617 | +12.8% | 0.06% | +156.5% |
| Q4 2019 | $280,000 | -67.9% | 5,865 | -66.5% | 0.02% | -69.7% |
| Q2 2019 | $873,000 | – | 17,510 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |